Sangamo Biosciences, Inc. (NASDAQ:SGMO)

CAPS Rating: 2 out of 5

The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.

Recs

1
Player Avatar TMFBiologyFool (97.10) Submitted: 9/29/2011 11:59:24 AM : Outperform Start Price: $4.60 SGMO Score: +163.60

Good technology, but things need to be worked out. This is more of a buy and forget stock.

Featured Broker Partners


Advertisement